NUCLIDIUM wins EIC Accelerator grant to further advance its CuTrace platform for personalised cancer diagnostics
The European Innovation Council (EIC) has awarded Nuclidium with its Accelerator grant of €2,5 million to develop novel, broadly available Copper-based PET tracers for the diagnosis of a broad range of cancer indications. The EIC Accelerator program focuses on high impact innovations and on creating new markets. The innovations considered for funding should be cutting-edge, and particularly focused on scientific and/or technological discoveries.
